Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 2,776,465 |
|
|||||
| News | (1) | ||||||
| Day High | 0.6864 | Low High |
|||||
| Day Low | 0.64 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0627 | -8.56% | 0.6699 | 18:47:44 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.65 | 0.64 | 0.6864 | 0.6648 | 0.7326 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,962 | 2,776,465 | US$ 0.6602529 | US$ 1,833,169 | - | 0.60 - 1.56 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:47:44 | formt | 100 | US$ 0.6699 | USD |
Citius Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 105M | 159.09M | - | 0 | -33.69M | -0.21 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Citius Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.81 | 0.8236 | 0.64 | 0.7420066 | 1,018,577 | -0.1401 | -17.30% |
| 1 Month | 0.91 | 1.07 | 0.64 | 0.8502267 | 1,256,051 | -0.2401 | -26.38% |
| 3 Months | 0.64 | 1.07 | 0.60 | 0.7954749 | 843,908 | 0.0299 | 4.67% |
| 6 Months | 0.7831 | 1.07 | 0.60 | 0.7763983 | 690,346 | -0.1132 | -14.46% |
| 1 Year | 1.41 | 1.56 | 0.60 | 1.00 | 1,044,961 | -0.7401 | -52.49% |
| 3 Years | 1.7922 | 4.56 | 0.60 | 1.97 | 2,000,578 | -1.12 | -62.62% |
| 5 Years | 1.05 | 4.56 | 0.40 | 1.82 | 2,249,834 | -0.3801 | -36.20% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome. |
